PureHealth acquires 60% stake in Hellenic Healthcare Group

EUROPE—PureHealth Holding PJSC, the largest healthcare group in the Middle East, has announced its acquisition of a 60% stake in Hellenic Healthcare Group (HHG), the leading private healthcare provider in Greece and Cyprus.

This transaction, which values HHG at US$2.3 billion, sees HHG’s ownership now divided between PureHealth, CVC Capital Partners, and the company’s founder.

CVC Capital Partners retains a 35% share, while the founder holds 5%.

HHG, with a network of 10 hospitals and 16 diagnostic centers across Greece and Cyprus, serves approximately 1.4 million patients annually.

The group’s facilities, with over 1,600 beds, provide a wide range of medical services, including specialties in oncology, cardiology, neurosurgery, and IVF treatments, which perform over 6,000 cycles each year.

Their comprehensive offerings also include homecare services, making HHG a key player in European healthcare.

The partnership between PureHealth and CVC strengthens PureHealth’s global expansion strategy.

CVC, a prominent private markets manager with US$201 billion in assets, has investments in over 130 companies worldwide, generating US$166 billion in annual sales.

Together, PureHealth and CVC aim to transform HHG into a larger organization, capitalizing on growth opportunities in the Greek and Cypriot healthcare markets.

 These regions present a favorable growth outlook, driven by rising demand for advanced medical services and increasing private healthcare investments.

A significant portion of healthcare spending in Greece is out-of-pocket, highlighting an unmet demand for private healthcare services and presenting an opportunity for HHG to fill this gap with quality care.

PureHealth plans to leverage its scale and capabilities to consolidate HHG’s position in the region while focusing on innovation, operational excellence, and improved patient outcomes.

PureHealth’s Chairman, Hamad Al Hammadi, expressed that the collaboration with global leaders like CVC highlights their ability to drive growth at scale.

Shaista Asif, Group CEO of PureHealth, noted that the acquisition marks a strategic milestone in expanding their European presence and reinforcing their position as a global healthcare leader.

CVC’s Alex Fotakidis added that HHG’s success under CVC reflects their commitment to growth and value creation.

He emphasized that partnering with PureHealth will help achieve their shared growth ambitions, bringing greater value to their patients and the communities they serve.

The transaction is subject to regulatory approvals and closing conditions, with further details to be announced.

This acquisition is part of PureHealth’s broader strategy to diversify its portfolio and establish itself as a global healthcare leader.

In recent years, PureHealth has completed key acquisitions, including Circle Health Group in the UK and a 26% stake in Ardent Health Services in the US, further solidifying its international presence and capabilities in healthcare investment and value creation.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.

Newer Post

Thumbnail for PureHealth acquires 60% stake in Hellenic Healthcare Group

Dawa Life Sciences: Three decades of transforming healthcare in East and Southern Africa

Older Post

Thumbnail for PureHealth acquires 60% stake in Hellenic Healthcare Group

Takeda partners with King Saud University Medical City to enhance healthcare training

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.